Otonomy (OTIC) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free OTIC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOtonomy, Inc. (OTIC) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 23 at 1:11 AMOtonomy, Inc.: Otonomy Provides Corporate Updatefinanznachrichten.de - December 21 at 12:04 AMOtonomy Provides Corporate Updatefinance.yahoo.com - December 19 at 6:40 PMmarketbeat.com - December 19 at 4:46 PM5 Investors Betting Big on Otonomy (OTIC) Stockinvestorplace.com - November 30 at 1:17 PMWhy Is Otonomy (OTIC) Stock Up 97% Today?investorplace.com - November 29 at 1:04 PMOtonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 10 at 6:24 PMOTIC.OQ - Otonomy Inc | Stock Price & Latest News | Reutersreuters.com - November 6 at 9:21 AMOTONOMY, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.commarketscreener.com - October 14 at 9:09 AMU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% By Investing.com - Investing.cominvesting.com - October 13 at 11:08 PMLianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial - Yahoo Financefinance.yahoo.com - October 13 at 11:08 PMU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% - StreetInsider.comstreetinsider.com - October 13 at 6:07 PMOtonomy shares are trading lower after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline. - Otonomy (NASDAQ:OTIC) - Benzingabenzinga.com - October 13 at 6:07 PMOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive - Marketscreener.commarketscreener.com - October 13 at 6:07 PMWhy Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid- - Benzingabenzinga.com - October 13 at 1:07 PMOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss - Marketscreener.commarketscreener.com - October 13 at 1:07 PMOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - GlobeNewswireglobenewswire.com - October 13 at 1:07 PMOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - Yahoo Financefinance.yahoo.com - October 13 at 8:07 AMOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Lossfinance.yahoo.com - October 13 at 8:06 AMOTIC.O - Otonomy Inc | Stock Price & Latest News | Reutersreuters.com - October 7 at 2:37 PMAPPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - September 27 at 9:36 PMOTONOMY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.commarketscreener.com - September 17 at 2:39 AMForm SC 13G/A OTONOMY, INC. Filed by: FEDERATED HERMES, INC. - StreetInsider.comstreetinsider.com - September 9 at 6:07 PMAGTC to Participate in Upcoming Investor Conferences - Yahoo Financefinance.yahoo.com - September 1 at 11:20 PMOtonomy : Costs Associated with Exit or Disposal Activities - Form 8-K - Marketscreener.commarketscreener.com - August 11 at 3:51 AMOTONOMY, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.commarketscreener.com - August 9 at 6:42 PMShort Volatility Alert: Otonomy, Inc. - Benzingabenzinga.com - August 6 at 5:18 AMThis Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarketbenzinga.com - August 3 at 8:34 AMOTIC stock downgraded at H.C. Wainwright as tinnitus candidate fails (NASDAQ:OTIC) - Seeking Alphaseekingalpha.com - August 2 at 7:36 PMHC Wainwright Downgrades Otonomy to Neutral From Buy - Marketscreener.commarketscreener.com - August 2 at 9:35 AMDaily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial By Benzinga - Investing.com UKuk.investing.com - August 2 at 9:35 AMOtonomy Shares Plumb New Depths on Failure of Lead Program >OTIC - MarketWatchmarketwatch.com - August 2 at 12:47 AMAGTC to Participate in Upcomin - GuruFocus.comgurufocus.com - August 1 at 7:35 PMPiper Sandler Adjusts Otonomy Price Target to $3 From $6, Maintains Overweight Rating - Marketscreener.commarketscreener.com - August 1 at 2:32 PMVirax, Aethlon top healthcare gainers; while Otonomy, Kazia lead losers' pack - Seeking Alphaseekingalpha.com - August 1 at 2:32 PMOtonomy Shares Sink After Stopping Mid-Stage Tinnitus Studyfinance.yahoo.com - August 1 at 2:32 PMOtonomy Reports Results From Phase 2 Clinical Trial Of OTO-313 In Patients With Tinnitus; Co. Reports 'OT - Benzingabenzinga.com - August 1 at 8:14 AMOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus - GlobeNewswireglobenewswire.com - August 1 at 8:14 AMOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitusfinance.yahoo.com - August 1 at 8:14 AMmarketbeat.com - August 1 at 7:25 AMOtonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.comamericanbankingnews.com - July 30 at 2:08 AMWalmart Cuts Q2, FY Profit Outlook; Stock Down - Nasdaqnasdaq.com - July 27 at 3:56 PMTwo Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design - Yahoo Financefinance.yahoo.com - July 27 at 3:56 PMOtonomy shares are trading lower after the company reported Q2 earnings results. - Benzinga - Benzingabenzinga.com - July 26 at 2:50 PMAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company's Design and Operating Procedures of its Planned cGMP Manufacturing Facility - Marketscreener.commarketscreener.com - July 26 at 9:47 AMHealthStream EPS Tops Estimate, MEDP Revises Forecast, OTIC To Report Tinnitus Trial Data In August - RTTNewsrttnews.com - July 26 at 9:47 AMOtonomy (NASDAQ:OTIC) Announces Quarterly Earnings Resultsmarketbeat.com - July 26 at 9:32 AMOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireglobenewswire.com - July 26 at 1:06 AMOtonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - July 25 at 8:06 PMOtonomy's Earnings Outlook - Benzinga - Benzingabenzinga.com - July 22 at 3:01 PM Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. OTIC Media Mentions By Week OTIC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTIC News Sentiment▼-0.240.33▲Average Medical News Sentiment OTIC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTIC Articles This Week▼00▲OTIC Articles Average Week Get Otonomy News Delivered to You Automatically Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADTX News Today SXTC News Today BLPH News Today ALLR News Today AMPE News Today EVLO News Today APVO News Today EVFM News Today SPRC News Today ATHX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OTIC) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Otonomy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
